Related Experiment Videos

[Streptococcus pyogenes: in vitro susceptibility to several antimicrobials in two date periods]

M S Giglio1, M Robles, M L Rioseco

  • 1Departamento de Microbiología, Facultad de Medicina, Universidad de Chile (Campus Occidente), Santiago de Chile.

Revista Medica De Chile
|June 1, 1996
PubMed
Abstract

Insights

Antimicrobial susceptibility testing of Streptococcus pyogenes strains revealed that while most remained susceptible to common antibiotics, a concerning increase in erythromycin resistance was observed in later isolates. This trend may be linked to macrolide usage.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • The incidence of severe Streptococcus pyogenes infections, including deep tissue invasion and toxic shock syndrome, has globally escalated.
  • This rise necessitates ongoing surveillance of bacterial susceptibility patterns.

Purpose of the Study:

  • To evaluate and compare the antimicrobial susceptibility profiles of Streptococcus pyogenes strains.
  • Specifically, to compare strains isolated in 1986 with those from 1994-1995.

Main Methods:

  • Microbiological analysis of 82 Streptococcus pyogenes strains from 1986 and 67 strains from 1994-1995.
  • Determination of Minimum Inhibitory Concentrations (MIC50 and MIC90) using agar dilution for key antibiotics: penicillin, ampicillin, cefazolin, cefuroxime, erythromycin, roxithromycin, and miocamycin.

Main Results:

  • All tested strains demonstrated susceptibility to penicillin, ampicillin, cefazolin, cefuroxime, roxithromycin, and miocamycin.
  • Ninety-nine percent of strains were susceptible to erythromycin.
  • Strains isolated in 1994-1995 exhibited higher MIC50 and MIC90 values for erythromycin compared to strains from 1986, indicating reduced susceptibility.

Conclusions:

  • Emerging resistance to erythromycin in recent Streptococcus pyogenes isolates is a significant finding.
  • This observed change in susceptibility is potentially associated with the increased utilization of macrolide antibiotics in Chile.

Related Concept Videos